Global CRO to Showcase Respiratory Expertise at 2022 ATS International Conference

Global CRO to Showcase Respiratory Expertise at

2022 ATS International Conference

WHAT:             Rho, a global full-service contract research organization (CRO), will showcase its expertise in pulmonary and respiratory related illnesses with attendees during the 2022 American Thoracic Society (ATS) International Conference, taking place at the Moscone Center in San Francisco, May 13-18.

Rho experts will be at booth #2203 to share their knowledge of the latest advances in the rapidly evolving field of pulmonary medicine, some of which include asthma, COPD and cystic fibrosis. They will be available for one-on-one interviews during the conference with those interested in learning more about Rho’s industry developments.

Based on Rho’s 25 years of NIH asthma research, that helped support the development of a cost-effective, patient-tailored asthma program, the global CRO recently conducted clinical trials for the Community Healthcare for Asthma Management and Prevention of Symptoms or “CHAMPS” project, funded by The Merck Childhood Asthma Network, Inc. and coordinated by researchers at George Washington University Milken Institute School of Public Health. The successfulness of the program has led to the implementation of this customized care in other US healthcare practices.

Rho has also conducted both pulmonary and gastrointestinal outcomes through inpatient and outpatient studies and has a comprehensive understanding of both the Cystic Fibrosis Foundation Therapeutics Development Network (CFF TDN) and the European Cystic Fibrosis Society (ECFS) Clinical Trials Network and their protocol assessment and feasibility processes.

Following study start-up for a Phase III cystic fibrosis study, the Cystic Fibrosis Foundation Therapeutics Development Network conducted a survey that found 100% of participating clinical sites ranked Rho as good or excellent. Rho also scored higher than the CFF TDN average.

Click hereto learn more about Rho’s respiratory expertise.

WHO:               Caitlin Hirschman, Principal Clinical Team Lead, Rho

Shannon Kirby, Senior Clinical Team Lead, Rho

Tony Gomez, Senior Director Business Development, Rho

Stephanie Wellford, Project Director, Rho

Nicole Rogers, Senior Project Manager, Rho

WHEN:                 Friday, May 13 – Wednesday, May 18

WHERE:            Booth #2203

Moscone Center

747 Howard Street, San Francisco, CA 94103

MEDIA CONTACT:             

Kelly Maicon 

Largemouth Communications 

(919) 741-9784; kmaicon@largemouthpr.com 

About Rho

Rho is a global, privately held contract research organization (CRO) headquartered in Research Triangle Park, a biotech hub in North Carolina, US. Rho provides a full range of drug development services, from program strategy through to clinical trials and marketing applications. For more than 36 years, Rho has been a trusted partner to some of the most innovative pharmaceutical, biotechnology and medical device companies as well as academic and government organizations. Dedicated to service excellence and cross-functional collaboration, Rho’s therapeutic expertise, employee focus and commitment to strong site relationships change what it means to work with a CRO – accelerating time to market, maximizing ROI, and delivering consistent, smarter and more efficient programs. Experience Rho by following the company on Facebook, LinkedIn, Twitter, and Instagram.